Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL2679632

CC(C)C(C)O.N.N

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL1333597 1.00
SCHEMBL2017195 0.94 ALDH1A1 (0.56)
SCHEMBL23875 0.94
SCHEMBL418078 0.94
SCHEMBL685153 0.94
SCHEMBL31518532 0.89
Hydrochloric Acid SCHEMBL6645496 0.89
SCHEMBL28881845 0.89
Methyl Alcohol SCHEMBL17241953 0.89
SCHEMBL27646234 0.89

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 138 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11945845-B2 Compositions and methods for regulation of chronic toxoplasma infection WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2024-04-02 US disclosed
EP-3597262-B1 FORMULATION FOR INTRACUTANEOUS INJECTION XERIS PHARMACEUTICALS INC (US) 2023-12-27 EP disclosed
EP-3031469-B1 CYTOMEGALOVIRUS SURFACE PROTEIN COMPLEX FOR USE IN VACCINES AND AS A DRUG TARGET UNIV PRINCETON (US) 2023-08-23 EP disclosed
US-11129891-B2 Cytomegalovirus surface protein complex for use in vaccines and as a drug target THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2021-09-28 US disclosed
WO-2020243675-A2 COMPOSITIONS AND METHODS FOR REGULATION OF CHRONIC TOXOPLASMA INFECTION WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2020-12-03 WO disclosed
EP-2526996-B1 Formulation for intracutaneous injection XERIS PHARMACEUTICALS INC (US) 2019-09-11 EP disclosed
US-10300130-B2 Cytomegalovirus vaccines and methods of production THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2019-05-28 US disclosed
US-20170014504-A1 CYTOMEGALOVIRUS VACCINES AND METHODS OF PRODUCTION THE TRUSTEES OF PRINCETON UNIVERSITY 2017-01-19 US disclosed
CN-106117322-A Recombinant influenza hemagglutinin (HA) antigen protein and containing its vaccine 刘大才 2016-11-16 CN disclosed
US-9439960-B2 Cytomegalovirus vaccines and methods of production THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2016-09-13 US disclosed
EP-0432220-A1 VACCINES AND DIAGNOSTIC ASSAYS FOR HAEMOPHILUS INFLUENZAE. PRAXIS BIOLOG INC (US) 1991-06-19 EP disclosed
WO-1991001143-A1 STABLE VACCINE COMPOSITIONS CONTAINING INTERLEUKINS PRAXIS BIOLOGICS, INC. (US) 1991-02-07 WO disclosed
EP-0390799-A1 RESPIRATORY SYNCYTIAL VIRUS: VACCINES PRAXIS BIOLOGICS, INC. (US) 1990-10-10 EP disclosed
WO-1990010458-A1 VACCINES FOR NONTYPABLE HAEMOPHILUS INFLUENZAE PRAXIS BIOLOGICS, INC. (US) 1990-09-20 WO disclosed
WO-1990006696-A2 MENINGOCOCCAL CLASS 1 OUTER-MEMBRANE PROTEIN VACCINE PRAXIS BIOLOGICS, INC. (US) 1990-06-28 WO disclosed
WO-1990002557-A1 VACCINES AND DIAGNOSTIC ASSAYS FOR HAEMOPHILUS INFLUENZAE PRAXIS BIOLOGICS, INC. (US) 1990-03-22 WO disclosed
EP-0294469-A4 VACCINES AND DIAGNOSTIC ASSAYS FOR HAEMOPHILUS INFLUENZAE. PRAXIS BIOLOG INC (US) 1990-02-05 EP disclosed
WO-1989002935-A1 RESPIRATORY SYNCYTIAL VIRUS: VACCINES AND DIAGNOSTIC ASSAYS PRAXIS BIOLOGICS, INC. (US) 1989-04-06 WO disclosed
EP-0294469-A1 VACCINES AND DIAGNOSTIC ASSAYS FOR HAEMOPHILUS INFLUENZAE. PRAXIS BIOLOG INC (US) 1988-12-14 EP disclosed
WO-1988004932-A1 VACCINES AND DIAGNOSTIC ASSAYS FOR HAEMOPHILUS INFLUENZAE PRAXIS BIOLOGICS, INC. (US) 1988-07-14 WO disclosed